The neuropathies observed in this trial, which included reversible polyneuropathy of multiple cranial nerves, have also not been observed with T cell engagers targeting other targets and suggest that PSMA-targeted T cell engagers may drive T cells to neurons directly or indirectly perhaps due to PSMA expression on nerves. The gene discussed is FOLH1; the disease is neuropathy.